Thermo Fisher Scientific Stock

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse 16:00:01 2024-04-26 EDT 5-day change 1st Jan Change
573.6 USD +0.33% Intraday chart for Thermo Fisher Scientific +5.29% +8.07%
Sales 2024 * 43.06B 58.85B Sales 2025 * 46.13B 63.05B Capitalization 219B 299B
Net income 2024 * 6.32B 8.64B Net income 2025 * 7.17B 9.8B EV / Sales 2024 * 5.61 x
Net Debt 2024 * 22.65B 30.96B Net Debt 2025 * 18.95B 25.9B EV / Sales 2025 * 5.16 x
P/E ratio 2024 *
35.2 x
P/E ratio 2025 *
30.2 x
Employees 122,000
Yield 2024 *
0.26%
Yield 2025 *
0.28%
Free-Float 87.14%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.33%
1 week+5.29%
Current month-1.31%
1 month+0.84%
3 months+4.80%
6 months+30.32%
Current year+8.07%
More quotes
1 week
543.15
Extreme 543.15
586.46
1 month
529.64
Extreme 529.64
589.93
Current year
527.32
Extreme 527.32
603.82
1 year
415.60
Extreme 415.6
603.82
3 years
415.60
Extreme 415.6
672.34
5 years
250.21
Extreme 250.21
672.34
10 years
107.33
Extreme 107.33
672.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 01-10-31
Director of Finance/CFO 57 01-05-31
Chief Tech/Sci/R&D Officer - 18-12-31
Members of the board TitleAgeSince
Chief Executive Officer 55 01-10-31
Director/Board Member 67 12-03-29
Director/Board Member 62 22-02-28
More insiders
Date Price Change Volume
24-04-26 573.6 +0.33% 1,438,184
24-04-25 571.7 -0.98% 1,184,004
24-04-24 577.4 +0.49% 2,035,044
24-04-23 574.6 +4.78% 2,543,991
24-04-22 548.4 +0.66% 1,522,884

Delayed Quote Nyse, April 26, 2024 at 04:00 pm

More quotes
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
573.6 USD
Average target price
618.2 USD
Spread / Average Target
+7.78%
Consensus